Available Until 2/3/2026

Pharmacotherapy Specialty Review Course for Recertification + Recert Exams Package (Cert # L259012)

ACPE Numbers: Various – see listing below
Content Release Date: February 5, 2025
Expiration Date: February 3, 2026
Activity Type: Application-based
CE Credits: 32 (BPS and ACPE) contact hours
Activity Fee: $505 (ASHP member); $715 (non-member)

Activity Overview

This course is intended for BCPSs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice. The course uses a case-based approach to discuss patient care issues. In this series, faculty will:

  • Review pertinent clinical topics and practice skills
  • List valuable resources for further self-study  

This online course consists of 26 activities (see table below) and provides up to 32 contact hours of continuing pharmacy education credit and/or recertification credit.

These activities were recorded during a live educational event on December 7-8, 2024 at the Midyear Clinical Meeting in New Orleans, Louisiana. Learners who claimed credit for the live activities should not claim ACPE credit for these home study activities.

The Core Therapeutic Modules Review Package consists of 10 activities in which faculty review clinical topics and practice skills using a case-based approach. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam.

Learning Activity

ACPE Number

Contact Hours

ACPE

Expiration

Date

Select Topics in Acid-Base Disorders

0204-0000-21-610-H01-P

1.25 ACPE

09/22/2024 

Select Topics in Infectious Diseases in Critical Care Patients

0204-0000-22-643-H01-P

1.0 ACPE

09/21/2025  

Select Neurology Topics in Critical Care Patients

0204-0000-20-990-H01-P

1.0 ACPE

09/22/2023

Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care

0204-0000-21-611-H01-P

1.0 ACPE

09/22/2024

Select Topics in Prevention and Supportive Care in Critical Care Patients

0204-0000-20-991-H01-P 1.0 ACPE 09/22/2023

Select Topics in Toxicology

0204-0000-21-612-H01-P 1.0 ACPE 09/20/2024

Select Topics in Pulmonary Disorders

0204-0000-22-644-H01-P 1.0 ACPE 09/21/2025

Cardiac Arrhythmias and Advanced Cardiac Life Support

0204-0000-20-992-H01-P 1.0 ACPE 09/22/2023

Pharmacotherapy Considerations in the Management of Shock

0204-0000-20-993-H01-P 1.0 ACPE 09/22/2023

Fluid, Electrolytes, and Nutrition

0204-0000-22-617-H01-P 1.0 ACPE 09/21/2025

After participating in these CPE activities, learners should be able to:

Select Topics in Acid-Base Disorders
ACPE #: 0204-0000-21-610-H01-P

For the following specific acid/base disorders - respiratory, metabolic acid base disorders including anion gap/non-anion gap acidosis, renal tubular acidosis, as well as delta gap equation:

  •  Interpret laboratory and diagnostic tests.
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines

Select Topics in Infectious Diseases in Critical Care Patients
ACPE #: 0204-0000-22-643-H01-P

For the following specific infectious disease topics: urinary tract infections, meningitis, catheter related infections, bacteremia, and infective endocarditis:

  • Interpret laboratory and diagnostic tests.
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.

Select Neurology Topics in Critical Care Patients
ACPE #: 0204-0000-20-990-H01-P

  • For the following specific critical care topics: status epilepticus, traumatic brain injury, ischemic stroke, subarachnoid hemorrhage:
    • Interpret laboratory and diagnostic tests.
    • Evaluate benefits and risks of drug therapy considering other medication, and other patient-specific factors.
    • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.

Alterations in Pharmacokinetics and Pharmacodynamics in Critical Care
ACPE #: 0204-0000-21-611-H01-P

  • Identify pharmacokinetic and pharmacodynamic (PK/PD) changes that occur in critical illness, and the impact on commonly administered medications in this setting.
  • Apply knowledge of general PK/PD changes in critical illness to the following patient-specific factors that further complicate drug dosing:
    • Burns
    • Obesity
    • Pregnancy
    • Continuous renal replacement therapy (CRRT)
    • Extracorporeal membrane oxygenation (ECMO)
  • Develop a therapeutic strategy to optimize PK/PK for commonly used medications in the intensive care unit. "

Select Topics in Prevention and Supportive Care in Critical Care Patients
ACPE #: 0204-0000-20-991-H01-P

For the following specific critical care topics─stress ulcer prophylaxis (SUP), venous thromboembolism (VTE) prophylaxis, bowel regimens, and ventilator associated pneumonia (VAP) prevention:

  • Interpret laboratory and diagnostic tests.
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.

Select Topics in Toxicology
ACPE #: 0204-0000-21-612-H01-P

For the following specific toxicology topics: acetaminophen, toxic alcohols, calcium channel blockers, beta blockers, opioids, and ecstasy:

  • Interpret laboratory and diagnostic tests
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.

Select Topics in Pulmonary Disorders
ACPE #: 0204-0000-22-644-H01-P

For the following specific pulmonary disease topics: asthma exacerbation, acute exacerbation of chronic obstructive pulmonary disease, pulmonary embolism, and pulmonary arterial hypertension:

  • Interpret laboratory and diagnostic tests.
  • Recommend the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.

Cardiac Arrhythmias and Advanced Cardiac Life Support
ACPE #: 0204-0000-20-992-H01-P

  • Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
  • Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
  • Identify strategies to prevent drug-induced arrhythmias.
  • Recommend therapy and monitoring for cardiac arrhythmias based on patient-specific information, current guidelines and Advanced Cardiac Life Support guided therapies.

Pharmacotherapy Considerations in the Management of Shock
ACPE #: 0204-0000-20-993-H01-P

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic)
  • Compare and contrast the pharmacologic agents utilized in shock
  • Recommend therapy and monitoring based on patient-specific information and current guidelines for the treatment of shock

Fluid, Electrolytes, and Nutrition
ACPE #: 0204-0000-22-617-H01-P

  • Interpret laboratory and diagnostic tests for fluid, electrolyte, and nutrition status.
  • Recommend the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.
  • Apply strategies to manage drug-related electrolyte interactions and nutrient interactions.